30 minutes
Although many clinical trials were disrupted, cancelled or delayed in 2020, the scientific R&D industry's response to the pandemic actually helped accelerate innovation in clinical trials. Our panelists will discuss the key trends that have emerged over the past year - including new models and partnerships, trial design, and the importance of diverse representation - and will assess what the future of clinical trials looks like.


Kate Owen - Senior Vice President and Head of Global Development Operations, Bristol Myers Squibb
Lauren Powell, MPA, PhD - VP Health Equity & Community Wellness, Takeda
Matthew B. Klein, MD, MS, FACS - Chief Development Officer, PTC Therapeutics
Michael Curry - President and CEO, Massachusetts League of Community Health Centers